REGEN BIOPHARMA, INC. (RGBPP) Operating income 2016–2025
REGEN BIOPHARMA, INC. (RGBPP) annual operating income history from SEC filings — each fiscal year as reported.
-$338,540FY2025 · since FY2016: -$3.0M → -$338,540
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$338,540 | +18.9% |
| FY2024 | -$417,221 | +39.3% |
| FY2023 | -$686,950 | -102.3% |
| FY2022 | -$339,605 | -69.2% |
| FY2021 | -$200,771 | +4.1% |
| FY2020 | -$209,317 | +72.3% |
| FY2019 | -$756,785 | +46.9% |
| FY2018 | -$1.4M | +43.2% |
| FY2017 | -$2.5M | +15.1% |
| FY2016 | -$3.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice